🚨🚨🚨 Thrilled to share our newest study — identifying functional long noncoding RNAs using transcriptome-scale RNA-targeting CRISPR screens.
🔎🔎🔎
We hope this scalable approach will be helpful for folks who want to connect noncoding RNAs to phenotypes & diseases.
🦋📷👑🦘#postdoc#opportunity alert! interested in joining us to develop exciting #RNA#cancer#crispr projects? Fellowship call open at https://t.co/SrN0TMvGnh Deadline 12 Oct
Major breakthrough: #CRISPR researchers have engineered a rice variant 🍚 resistant to multiple pathogens, including the devastating rice blast fungus, without reducing yield. A revolution for global food security as rice is a staple for 1/2 of the world. https://t.co/kWQEts5UVs
Spatial isoform Transcriptomics (SiT) is now published in @NAR_Open.
Combining @10xGenomics#Visium and @nanopore long-read, we explore the spatial landscape of gene expression isoforms in mouse brain sections.
@pbarbry@joalunatkthse@fr_genomics@CNRS
https://t.co/1PAKpKJXp3
Thrilled to share our work on Gene Editing for #GM1#gangliosidosis. Base Editing seems to be an alternative approach to treat patients @CureGM1
by @Delphine_Lclrc : She is looking for a PostDoc position !!!!!
@Inserm, @CSignaling https://t.co/5VhXkF4Lbd
@FAO releases a report on gene editing in ag. @doudna_lab writes “we can alter nutritional content to combat malnutrition, remove toxins from staple foods, increase yields to fight hunger, improve pest resistance, reduce the need for agrochemical inputs.
https://t.co/FdisdLPaRm
GOLD Lab is hiring! We seek talented and ambitious young scientists for cutting-edge experimental AND quantitative/computational projects at PhD/postdoc level. Details here: https://t.co/ECBKuBw1QW **please retweet / share**
Interested in CRISPR and Huntington’s disease? Check out this @jclinicalinvest paper: an allele-specific strategy targeting mutant HTT via nonsense-mediated decay! 🧬 ✂️ https://t.co/tYToyZNRaj
Les #FemmesEnScience et leurs contributions à un monde vivable, durable et inclusif méritent de rayonner 👩🔬
À travers leurs travaux innovants, six Jeunes Talents 2022 #FWIS @FondationLOreal-@UNESCO sont au cœur de la lutte contre des maladies rares, génétiques et cancéreuses �Les #FemmesEnScience et leurs contributions à un monde vivable, durable et inclusif méritent de rayonner 👩🔬
À travers leurs travaux innovants, six Jeunes Talents 2022 #FWIS @FondationLOreal-@UNESCO sont au cœur de la lutte contre des maladies rares, génétiques et cancéreuses �Les #FemmesEnScience et leurs contributions à un monde vivable, durable et inclusif méritent de rayonner 👩🔬
À travers leurs travaux innovants, six Jeunes Talents 2022 #FWIS @FondationLOreal-@UNESCO sont au cœur de la lutte contre des maladies rares, génétiques et cancéreuses �Les #FemmesEnScience et leurs contributions à un monde vivable, durable et inclusif méritent de rayonner 👩🔬
À travers leurs travaux innovants, six Jeunes Talents 2022 #FWIS @FondationLOreal-@UNESCO sont au cœur de la lutte contre des maladies rares, génétiques et cancéreuses �Les #FemmesEnScience et leurs contributions à un monde vivable, durable et inclusif méritent de rayonner 👩🔬
À travers leurs travaux innovants, six Jeunes Talents 2022 #FWIS @FondationLOreal-@UNESCO sont au cœur de la lutte contre des maladies rares, génétiques et cancéreuses �Les #FemmesEnScience et leurs contributions à un monde vivable, durable et inclusif méritent de rayonner 👩🔬
À travers leurs travaux innovants, six Jeunes Talents 2022 #FWIS@FondationLOreal-@UNESCO sont au cœur de la lutte contre des maladies rares, génétiques et cancéreuses 👏
4/These profound reductions in serum TTR were sustained throughout the observation period - ranging from 2 to 6 months.The data supports $NTLA-2001 as a one-time treatment to permanently inactivate the TTR #gene thus reducing the disease-causing protein in patients with #ATTR-CM.
Our work @doyonlab is officially out @NatureComms! Here’s a thread on how co-selection facilitates prime editing (PE) in human cells and how we uncovered previously unappreciated PE3-mediated DNA repair outcomes. https://t.co/jgMZlXyFqd